The Surgeon General blames the lack of research on marijuana for its Schedule I status. However, there is more to this argument than just the lack of research. According to Dr. Mark Rosenfeld, CEO of ANANDA Scientific, the substance could have a variety of medicinal benefits, while also being highly cost-effective. Cannabis’ medicinal uses have …
Continue reading “Surgeon General Blames Lack of Marijuana Research on Schedule I Status”